Сердечно-сосудистые осложнения сахарного диабета 2-го типа (продолжение...)

  • Reiber G., Boyko E., Smith D. Lower extremity foot ulcers and amputations in diabetes. In: M. Harris, C. Cowie, M. Stem, E. Boyko, G. Reiber, P. Bennett, eds. Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Healh 1995; 409-428.
  • UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
  • Alberti K.G.M.M., Zimmet P.Z. for the Who consulation. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a World Health Organization consultation. Diabet Med 1998; 15: 539-553.
  • Ashcroft F.M., Gribble F.M. ATP sensitive K+ channels and insulin secretion: their role in health and disease. Diabetologia 1999; 42: 903-919.
  • Bruttomesso D., Pianta A., Verio A. et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes 1999; 48: 99-105.
  • Palmer K.J., Brogden R.N. Gliclazide, in update on its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. Drugs 1993; 46: 92-125.
  • Bak J.F., Schmitz O., Niels S.S., Pedersen O. Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients. Diabetes 1989; 38: 1343-1350.
  • Jenings Р.Е., Scott N.A., Saniabadi A.R., Belch J.J.F. Effects of gliclazide on platelet reactivity and free radicals in type 2 diabetic patients: clinical assessment. Metabolism 1992; 41 (5 suppl 1): 36-39.
  • Florkowski C.M., Richardson M.R., Le Guen C. et al. Effect of parameters of hemostasis, lipid gliclazide on thromboxane B2 peroxides and fluorescent IgG in type 2 diabetes mellitus. Diabe-tologia 1988; 31: 490A.
  • Jennings A.M., Wilson R.M., Ward J.D. Symptomatic hypoglycemic agents. Diabetes Care 1989; 12: 201-208.
  • Van Staa T., Abenhaa L., Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997; 50: 735-741.
  • Mychka V., Gornostaev V., Dmitriev V. et al. Effect of perindopril on 24-hours ambulatory blood pressure monitoring, carbohydrates and lipids metabolism in patients with mild and moderate arterial hypertension and metabolic syndrome. J Hypertens 2001; 19 (suppl 2): S283.
  • В.Б. Мычка, В.В. Горностаев, И.Е. Чазова

    Отдел системных гипертензий Института клинической кардиологии им. А.Л. Мясникова Российского кардиологического научно-производственного комплекса Минздрава Российской Федерации, Москва






    Наиболее просматриваемые статьи: